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LETTERS TO THE EDITOR
Laser Angioplasty and Atherosclerosis
The assertion of Isner and Clarke (I) "without equivocation" that
"laser-generated light eliminates atherosclerotic plaque" is not
true, if by "eliminate" they mean "remove completely." On the
contrary, lasers have merely been demonstrated to bore a hole in
a plaque by vaporizing material in the path of the beam, which is
quite different from eliminating the plaque. What they describe as
laser angioplasty is actually a form of incomplete endarterectomy.
It is important to remember that atherosclerosis is not simply
a deposit within the vessel wall, but a transformation of the intima
into an atherosclerotic plaque, with alteration of the media (2).
Endarterectomy, which is necessarily incomplete when performed
by laser, does not leave behind a normal vessel. It is unrealistic
to think of local vaporization of a portion of a plaque as elimination
of the plaque. Moreover, atherosclerosis is a diffuse disease and
is not confined to the area of worst narrowing as seen on angi-
ography (3).
Based on the poor long-term results of local (mechanical) end-
arterectomy without bypass (4), there is no reason to assume that
the results of incomplete local endarterectomy performed by laser
should be any better. It is a mistake to think that lasers have the
power to make atherosclerotic lesions magically disappear.
It may be that the Gordian knot cannot be unraveled: Once
structural changes take place in the vessel wall, it may be impos-
sible to return that vessel to its predisease state. As in so many
diseases, the only true "cure" lies in prevention.
GERALD S. WEINSTEIN, MD, FACC
130 East 77th Street
New York, New York 10021
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Reply
As Weinstein correctly points out, we did not intend to imply that
clinical application of laser irradiation is likely to restore an ath-
erosclerotic coronary artery to its virgin, nonpathologic state. As
he, and we (his Ref. 2), have indicated, the fact that the athero-
sclerotic process permanently alters the normal architecture of the
coronary wall (by "eliminating" a substantial portion of medial
smooth muscle) implies that restoration of a truly normal coronary
artery is an unrealistic end point.
JACC Vol. 8, No. I
July 1986:254---6
In contrast to alternative, so-called definitive interventions,
however, laser irradiation does, in fact, "eliminate" atheroscle-
rotic plaque: rather than a stenosis that persists unchanged after
bypass surgery, or an atherosclerotic lesion that persists in re-
modeled form after balloon angioplasty, a substantial portion of
atherosclerotic plaque may be effectively debulked by laser irra-
diation.
Weinstein is also correct in pointing out that laser ablation of
atherosclerotic plaque is similar in many respects to mechanical
endarterectomy, except, of course, that laser irradiation offers the
potential of a percutaneous, as opposed to open chest, procedure.
Whether the clinical results that can be accomplished using laser
irradiation will be superior to those previously achieved by me-
chanical endarterectomy is admittedly a critical question that must
be resolved by animal or human investigations, or both.
JEFFREY M. ISNER, MD, FACC
Associate Professor of Medicine and Pathology
Tufts University School of Medicine
Associate Director, Cardiac Catheterization Lab
New England Medical Center
171 Harrison Avenue
Boston, Massachusetts 02111
Manipulating the aT-eT
O'Donnell et al. (I) found that the aT-eT interval (time from the
apex to the end ofthe T wave) was significantly shorter at maximal
or near-maximal heart rates in the groups with than in the groups
withoutcoronary artery disease. They used another index, T slopelT-
arnplitude (ratio of the maximal slope of the descending limb of
the T wave to its amplitude), and found a similar separation. On
closer analysis, however, it is apparent that this more complicated
index is not materially different from aT-eT, and indeed is virtually
its reciprocal.
Using their Figure I, it can be seen that the descending limb
of the T wave is approximately linear so that its second part is
almost triangular. A reasonably accurate estimate of T slope is
then (-) T amplitude/aT-eT. The index of O'Donnell et aI., which
is T slope divided by T amplitude, is thus merely (-) l/aT-eT.
Predictably, during exercise this index increases numerically but
negatively as aT-eT decreases in the groups with disease (their
Fig. 2). To be sure, other variables, such as a less sharp T wave
apex, or a curved T wave descent, affect the validity of approx-
imating the index to (-) l/aT-eT. That these variables compared
with aT-eT are minor can be deduced from the observation that
the product of aT-eT and the corresponding index (obtained from
their Tables 3 and 4) is fairly constant. Multiplying aT-eT by the
index, its reciprocal, eliminates it so that the constancy of the
resultant product implies that other variables are relatively un-
important.
The authors concluded that "there is considerable overlap in
the individual data" for aT-eT so that its sensitivity and specificity
as a marker of disease were impaired. However, while the absolute
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Figure 2. Effect of intravenous verapamil (10 mg) on the junc-
tional rhythm. From top to bottom: there are no changes in the
junctional cycle length after verapamil. HRA = high right atrial
electrogram.
junctional rhythm rate. In a more recent clinical study, Hariman
et al. (3), by analyzing the response of junctional rhythm to over-
drive suppression, suggested that in some patients the location of
junctional rhythms may be indeed the N region of the atrioven-
tricular (AV) node; unfortunately, the responseof junctional rhythm
to verapamil to "confirm" the node location of the pacemaker
was not tested. In contrast, Schwartz et al. (2) recently reported
that, whatever the origin of the junctional rhythms, intravenous
verapamil enhances junctional automaticity in humans.
We report a case of a stable junctional rhythm at a rate of
80/min in a patient, a 58 year old woman, with sick sinus syn-
drome. Electrophysiologic study showed that the postpacing pauses
were more markedly prolonged after atrial pacing than after His
bundle pacing, even in the presence of 2: 1 AV node block, sug-
gesting that the junctional pacemaker was located cranial to the
His bundle; in fact, the His bundle was driven at a rate slower
than the spontaneous junctional rate during 2: 1 block (75/min)
(Fig. 1); thus, a pacemaker located below the AV node may not
have been suppressed. Intravenous verapamil (10 mg), in the ab-
sence of changes in systemic blood pressure, induced no change
in either the junctional rhythm rate (Fig. 2) or the postpacing
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Figure 1. Effect of overdrive suppression after atrial (AP) and
His bundle (HBP) pacing. From top to bottom: atrial and His
bundle pacing (cycle length [CLl 600 ms) for 1 minute were
followed by prolongation of junctional cycle length from 850 to
1,160 ms and from 850 to 960 ms, respectively (top two panels).
Atrial pacing at a cycle length of 400 ms results in 2: I AV node
block and in a prolongation of junctional cycle length from 850
to 1,200 ms (third panel from top); His bundle pacing at the
same cycle length (400 ms) results in 1: I conduction but in a
prolongation of junctional cycle length from 850 to 960 ms (bot-
tom panel). Time lines are at 1 second intervals and the paper
speed is 25 mmls. H = His bundle deflection; HBE = His bundle
electrogram; S = pacing spike.
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Recently, Hariman and Chen (I) and Schwartz et al. (2) reported
contrasting results on the effect of verapamil on junctional rhythms.
In particular, Hariman and Chen (1) postulated that the location
of the pacemaker in dogs with junctional rhythm induced by sinus
node ablation is the N region of the node. This assumption was
mainly suggested by the suppressive effect of verapamil on the
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values may overlap, individual data showing the change in aT-eT,
or ~ aT-eT, with exercise may quite possibly be a much improved
marker, and it would be useful for the authors to perform this
analysis.
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